Learn what semaglutide is, what a clinician may consider during a telehealth evaluation, and how to prepare for an informed conversation about medical weight-management options.
Semaglutide is a prescription medication in the GLP-1 receptor agonist class. GLP-1 is a hormone involved in appetite and blood sugar regulation. Specific FDA-approved uses depend on the product and dose; a clinician can help explain which questions are relevant to your health history.
GLP-1 receptor agonists act on a pathway involved in appetite and blood sugar regulation. That general mechanism does not determine whether a medication is appropriate, safe, available, or covered for one person.
A medication name alone is not a treatment plan. The evaluation focuses on your individual health context.
Your clinician may review your current medications, prior treatment, relevant health history, goals, and questions.
Semaglutide may be discussed along with other medical weight-management options when clinically appropriate.
The clinician may discuss potential risks, benefits, alternatives, labs, follow-up, or whether in-person care is needed.
The Initial GLP-1 Evaluation is $100. Medication, pharmacy, laboratory, delivery, refill, and future-visit costs are separate unless explicitly stated.
Understand GLP-1 consultation costs ->Care is subject to clinical evaluation. A clinician may recommend a different option, additional information or testing, follow-up, or in-person care instead of prescribing medication.
Review GLP-1 labs and eligibility questions ->Explore how Kosius approaches GLP-1 weight management, including a clinician-led evaluation and questions to ask before treatment decisions are made.
Read the GLP-1 weight management guide ->Semaglutide is a prescription medication in the GLP-1 receptor agonist class. GLP-1 is a hormone involved in appetite and blood sugar regulation. Specific FDA-approved uses depend on the product and dose, and a clinician can explain which questions are relevant to your situation.
No. Medications in this category can differ in active ingredient, approved use, dose, risks, availability, and cost. A clinician can discuss options that may be relevant after clinical evaluation.
Yes. A Georgia-licensed clinician may discuss semaglutide during a scheduled telehealth evaluation when you are physically located in Georgia. Care is subject to clinical evaluation, and prescriptions are not guaranteed.
No prescription is guaranteed. The clinician will review your health history, goals, current medications, risks, and possible next steps before making an individual treatment decision.
No. The $100 fee is for the Initial GLP-1 Evaluation. Medication, pharmacy, laboratory, delivery, refill, and future-visit costs are separate unless explicitly stated.
Some patients may need laboratory work or other information before a treatment decision. Your clinician will discuss what may be appropriate for your situation.
Book a scheduled virtual evaluation while physically located in Georgia.
Book Initial GLP-1 Evaluation
